1. ALLA AKTIER
  2. NYHETER
  3. INTELLEGO TECHNOLOGIES

Intellego Technologies

Nyheter Intellego Technologies Nyheter alla bolag

Intellego enters negotiations with global pharma group

Intellego has initiated negotiations with one of the world’s largest companies in the pharmaceutical consumables and production sector. This US-based company has over 10,000 employees and operates in more than 150 countries. It is a subsidiary of one of the world’s leading pharmaceutical groups, which employs over 80,000 people globally.

The company has spent the past nine months evaluating Intellego’s UV LED dosimeters and the market, yielding positive results. The aim of this collaboration is to launch Intellego’s UV LED dosimeters, and potentially other dosimeter products, on the global market which has an estimated value of EUR 2 billion per year.

The launch is planned for 2025, with sales expected to increase progressively over time.

Contacts

For further information, please contact:
Claes Lindahl, CEO Intellego Technologies AB
E-mail: claes.lindahl@intellego-technologies.com
Phone: +46 735 344 634

About Us

Intellego Technologies develops and manufactures color indicators that show the effect of irradiation with, among other things, invisible ultraviolet light, UV light. Color indicators are used globally in, for example, the disinfection industry, the sunscreen industry, and the manufacturing industry. Intellego's indicators have been developed from the company's patented photochromic ink, which can be adapted to different wavelengths of light and various application areas across a range of different industries. Intellego Technologies was founded in 2011, is headquartered in Stockholm, and is listed on the Nasdaq First North Growth Market.
The company's Certified Adviser on the Nasdaq First North Growth Market Stockholm is Carnegie Investment Bank AB (publ).

Intellego's website: https://intellego-technologies.com/en/

Subscribe to Intellego's press releases: https://intellego-technologies.com/sv/pressmeddelanden/

Contact the communications team: communications@intellego-technologies.com

Attachments

Intellego enters negotiations with global pharma group

Datum 2024-11-20, kl 10:00
Källa MFN
Bifogade filer
Intellego enters negotiations with global pharma group
Affiliate
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet